• inhibits platelet aggregation
• used with heparin and aspirin as adjunct to percutaneous transluminal coronary angioplasty

• 0.25mg/kg over at least 1 minute given 10-60 minutes pre procedure

• run at 10 ug/min for 12 hours post cardiac catheterization
• should be administered with a 0.2 micron filter
• requires dedicated line

• bleeding
• thrombocytopenia
• numbness or peripheral pain
• nausea
• hypotension
• arrhythmias
• nausea

• should not be readministered to patients due to potential antibody formation with initial dose

INR/PTT

platelet count

bleeding

ECG

• Must be administered by a physician.
• Should not be infused through the injection port of the right heart catheter.
• Must be administered as a continuous infusion via an infusion pump.